Q2 2023 13F Holders as of 30 Jun 2023
-
Type / Class
-
Equity / Common Stock, $0.001 par value
-
Shares outstanding
-
99,337,748
-
Total 13F shares
-
101,711
-
Share change
-
+101,711
-
Total reported value
-
$205,455
-
Price per share
-
$2.02
-
Number of holders
-
7
-
Value change
-
+$205,455
-
Number of buys
-
7
Institutional Holders of PLUS THERAPEUTICS, INC. - Common Stock, $0.001 par value (PSTV) as of Q2 2023
As of 30 Jun 2023 PLUS THERAPEUTICS, INC. - Common Stock, $0.001 par value (PSTV) had 7 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 101,711 shares of stock of the company.
Largest 7 holders included VANGUARD GROUP INC, GEODE CAPITAL MANAGEMENT, LLC, BlackRock Inc., Tower Research Capital LLC (TRC), OSAIC HOLDINGS, INC., WELLS FARGO & COMPANY/MN, and GROUP ONE TRADING, L.P..
This table shows 7 institutional shareholders of the security as of 30 Jun 2023.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.